These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14997963)

  • 1. The value of serum creatine kinase in early diagnosis of heterotopic ossification.
    Sherman AL; Williams J; Patrick L; Banovac K
    J Spinal Cord Med; 2003; 26(3):227-30. PubMed ID: 14997963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury.
    Singh RS; Craig MC; Katholi CR; Jackson AB; Mountz JM
    Arch Phys Med Rehabil; 2003 Nov; 84(11):1584-8. PubMed ID: 14639555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterotopic ossification mimicking infection in patients with traumatic spinal cord injury.
    Citak M; Grasmücke D; Salber J; Cruciger O; Meindl R; Schildhauer TA; Aach M
    Technol Health Care; 2016; 24(1):87-91. PubMed ID: 26409557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of etidronate on late development of heterotopic ossification after spinal cord injury.
    Banovac K
    J Spinal Cord Med; 2000; 23(1):40-4. PubMed ID: 10752873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Sherman AL; Estores IM; Banovac F
    J Spinal Cord Med; 2004; 27(4):376-82. PubMed ID: 15484668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of heterotopic ossification in patients with spinal cord injury.
    Banovac K; Gonzalez F
    Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum alkaline phosphatase and inorganic phosphorus values in spinal cord injury patients with heterotopic ossification.
    Kim SW; Charter RA; Chai CJ; Kim SK; Kim ES
    Paraplegia; 1990 Sep; 28(7):441-7. PubMed ID: 2123534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
    Estrores IM; Harrington A; Banovac K
    J Spinal Cord Med; 2004; 27(5):434-7. PubMed ID: 15648796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory heterotopic ossification with complications.
    Yin KS; James J; Lew K; Little JW
    J Spinal Cord Med; 2001; 24(2):119-22. PubMed ID: 11587419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.
    Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC
    J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting heterotopic ossification following spinal cord injury.
    Xie Y; Zhang J; Jin X; Liu S; Song W
    Clin Neurol Neurosurg; 2024 Aug; 243():108348. PubMed ID: 38833809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury.
    Citak M; Grasmücke D; Suero EM; Cruciger O; Meindl R; Schildhauer TA; Aach M
    Spinal Cord; 2016 May; 54(5):368-70. PubMed ID: 26643987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series.
    Svircev JN; Wallbom AS
    J Spinal Cord Med; 2008; 31(2):194-6. PubMed ID: 18581667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle localization of heterotopic ossification following spinal cord injury.
    Ohlmeier M; Suero EM; Aach M; Meindl R; Schildhauer TA; Citak M
    Spine J; 2017 Oct; 17(10):1519-1522. PubMed ID: 28456672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnosis of heterotopic ossification among patients admitted to a neurological Post-Intensive Care Rehabilitation Unit.
    Carpentier VT; Salga M; Gatin L; Genêt F; Paquereau J
    Eur J Phys Rehabil Med; 2021 Aug; 57(4):527-534. PubMed ID: 33448758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review.
    Zakrasek EC; Yurkiewicz SM; Dirlikov B; Pence BT; Crew JD
    Spinal Cord; 2019 Mar; 57(3):214-220. PubMed ID: 30254206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure ulcer reconstruction in patients with heterotopic ossification after spinal cord injury: A case series and review of literature.
    Yang K; Graf A; Sanger J
    J Plast Reconstr Aesthet Surg; 2017 Apr; 70(4):518-528. PubMed ID: 28100407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury.
    Bravo-Payno P; Esclarin A; Arzoz T; Arroyo O; Labarta C
    Paraplegia; 1992 Oct; 30(10):740-5. PubMed ID: 1448303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.